We propose that whether mutant CARP1 leads to HCM or DCM may be correlated to differential effects on protein–protein interaction and in particular distinct activation of the two signalling pathways via ERK1/2 from the sarcomere to the nucleus (HCM) or via PKCα at the ID (DCM). The gene discussed is MAPK3; the disease is familial dilated cardiomyopathy.